End of the market competition

In the layout of the front of the medicinal herbs, Kang beauty firmly control the end of the market of traditional Chinese medicine. Since last year, the United States has been in the United States to create a rather fashionable concept - wisdom pharmacy".

October 9th, Kang beauty wisdom pharmacy first wisdom medical service area in Guangdong Province Traditional Chinese Medical Hospital officially completed. According to the U.S. official website released the illusions about the wisdom of the medical service area is the wisdom of pharmacy joint Guangdong Province Traditional Chinese Medical Hospital jointly launched a one-stop medical service can undertake wisdom, the wisdom of the hospital medical service.

"Chinese herbal medicine are late also need decoction, and is not convenient to use." Said the vice president of the East High St. and Dong Qu Rongzai times weekly reporter interview, now is to cooperate with the hospital pharmacy by Kang beauty wisdom wisdom system of pharmacy, the patients will be sent to the electronic prescription by Kang Kang beauty, the United States completed the deployment of drugs, traditional Chinese medicine decoction and distribution, the former in the hospital complex take the process of drug and go home after decocting trouble direct simplified "express" is as simple as.

Weekly Times reporter survey found that the wisdom of the U.S. pharmaceutical pharmaceutical pharmacy began in 2015. This year in June, deputy director of the State Planning Commission, director of the State Administration of traditional Chinese medicine Wang Guoqiang in Guangdong, made a special trip to Guangzhou Panyu Kangmei pharmaceutical pharmacy on the wisdom of investigation.

According to industry insiders, currently in the field of wisdom pharmacy, there are a number of domestic listed companies are the first layout, such as the wisdom of the Chinese medicine house, 600998.SH.

According to the Jointown related to the weekly Times reporter, the core of wisdom is to provide pharmacy prescription dispensing, storage management, prescription (decoction, paste, pill, powder), logistics and distribution services, "from the prescription to the decoction, one-stop service".

And in this field, the listed companies are competing. Such as the current in Beijing, Shanghai, Chongqing, Henan, Hubei, Gansu and other places of the 9 wisdom pharmacies have entered a state of formal operations.

According to Kang beauty Securities Department sources, at present, the wisdom of the pharmacy project in Guangzhou, Shenzhen and Beijing 3 cities landing, this year will be extended to Shanghai and Chongqing, to the end of this year will have 6 city layout. And this is the main business of Chinese Herbal Pieces Kang beauty, will enhance the sales volume.

Wisdom pharmacy sales of traditional Chinese medicine to promote the role is very obvious, Shenzhen Chinese medicine hospital, for example, Kang beauty in the past only accounted for 10% of the share of traditional Chinese medicine, because the wisdom of pharmacy to enter, and now accounts for 40%-50%." Told the times weekly newspaper reporter.

In fact, more than a year after the implementation of the wisdom of the pharmacy, the outside world is not clear about the layout of the field of health and beauty sales have contributed to the company's annual report in the company has not been disclosed.

"No (the wisdom of pharmacy sales brought the performance) proposed separate accounting, or go to pieces sold inside, because it (PIN) volume is not large, but we carry out the wisdom of pharmacy of the hospital, a majority is with us before the hospital is overlapping pieces sales." Hong Mei Securities Department told investors to call the identity of the weekly Times reporter, may have a few years of its (Sales) amount to a certain extent, it will be singled out.

According to the U.S. in 2016 semi annual disclosure of Chinese herbal medicine company during the reporting period, operating income of 1 billion 986 million yuan, an increase of 33.71%, the company continues to expand the wisdom of pharmacy, hospital pharmacy trusteeship and pharmaceutical operations, terminal market and other business channels, through the synergistic effect of each part of the business of the industrial chain, driven by Chinese herbal medicine business growth".

Of course, in the process of promoting the wisdom of pharmacy, will encounter a lot of obstacles. Domestic distribution of a large listed companies in the wisdom of the distribution business, told reporters times weekly newspaper reporter, its business in the process of advancing, facing a lot of problems.

For example, the first is a policy issue, due to the wisdom of pharmacy project is a new business model, Chinese herbal medicine pharmacy wisdom stored in the warehouse, did not enter the medical institutions, and in the process of monitoring the pharmaceutical sector are not consistent with the current policy requirements, faced with inconsistent accounts, zero goods settlement, GSP transfer etc.. Currently, the country only Zhengzhou and Shanghai have relevant policies to support the development of smart pharmacy project.

In addition, the problem of uneven quality of Chinese herbal medicine is generally second lead business development bottleneck, facing the vicious competition, poor quality cheap products to sell good quality, the price is high but not popular, smart pharmacy is providing value-added services, the core is to guarantee the quality of Chinese herbal medicine sales, so in business at present is also facing challenges". The person told the times weekly reporter.Project expansion frequently

In addition to the above and Chongqing signed a strategic cooperation agreement, the United States and the United States in recent years to increase the pace of expansion.

In September 30th, the U.S. released a number of consecutive investment announcement, one of which is the acquisition of Guangdong Pharmaceutical Co., Ltd. 80% stake, the total purchase price of 60 million yuan. The company's main business is engaged in pharmaceutical distribution business in Jiangmen region, the acquisition is completed, will help improve the company's drug distribution capabilities in Jiangmen region".

In addition, the U.S. subsidiary company to be funded the establishment of Kang beauty hospital management (Bozhou) Co., Ltd. (tentative name, registered capital of 50 million yuan), the hospital will be mainly engaged in the investment, construction and management, enterprise management consulting. At the same time, the U.S. also spent 23 million yuan, the acquisition of Shenzhen ieman Pharmaceutical Co., Ltd. 100% equity and capital 35 million yuan to the.

This continuous acquisition and investment, Kang beauty seems to be the main industry to consolidate the existing. This Chinese herbal medicine and Chinese herbal pieces as the core of the business, business covers Western medicine, health food, Chinese herbal medicine market operations, medical services, etc..

Since the first half of this year, the United States and the United States continued to increase the pace of investment. According to its semi annual report 2016 disclosure, the company invested a total of 1 billion 551 million yuan, compared with the same period last year 392 million yuan, an increase of 1 billion 159 million yuan, an increase of 295.70%.

In the continued expansion of the situation, in July 28th this year, the U.S. China disclosure and Guangdong branch of China Unicom signed a strategic cooperation agreement announcement, but on the 29 day he received the Shanghai Stock Exchange listed company supervision department issued a letter of inquiry.

The Shanghai Stock Exchange said, "your company in recent years, has released a number of signed a strategic cooperation agreement announcement, but in the announcement that the above agreement is a strategic cooperation agreement of cooperation agreement, specific co-operation with the parties signed prevail, the company will promptly disclose the progress".

Up to the requirements of the United States to supplement the disclosure of nearly a year, the company announced the follow-up progress of the relevant strategic cooperation agreement, cooperation status, problems and obstacles, and fully prompt the risk.

In this regard, Kang beauty breath disclosed 8 strategic cooperation agreement signed since September 2015, the Qinghai provincial government, partners include insurance capital, the government of Baoan District, Guangzhou University of Chinese Medicine, Shenzhen Galaxy Holdings Group, Huaiji county government, Guangdong health and planning students in Puning City Sports Bureau, the Yunnan provincial government and the China Unicom China.

The weekly Times reporter noted, in Concord in reply to the announcement, the existing problems and obstacles, the uniform reply is, "project in advance, the company will be based on the progress in the matter, fulfill the obligation of information disclosure".

Kang beauty continued business expansion in the circumstances, to conceal the financial worries.

Reported in the first half of 2016, the disclosure of its balance sheet, short-term borrowings reached 6 billion 599 million 500 thousand yuan, the reasons for changes in short-term borrowings: mainly due to the expansion of the company's operating scale of the reporting period."

In September 9th, the United States announced that the United States announced that it has recently issued a total of 2016 ultra short term financing for the first phase of the year, the actual total issuance of 3 billion yuan. The funds raised in September 8th included the company designated account. Although the short-term financing to the huge amount of money, but its duration of 270 days, the payment date for June 5, 2017, the issue of interest rates 2.98%.

The same day in September 9th, Meida shareholders Kang Kang beauty industry Co. Ltd. (hereinafter referred to as the "health beauty industry") held by the company of its tradable shares 100 million shares (representing 2.02% of total share capital) to carry out the stock pledged repo transactions.

Kang Kang beauty industry reputation, the equity pledge is mainly to meet the needs of business development. Times weekly reporter noted that the United States and the United States has almost all of the shares of the United States has pledged a health and beauty.

Kang as of this announcement, China, Hong Mei Industrial Company holds a total of 1 billion 547 million shares, accounting for 31.27% of the total share capital. Kang Mei Industrial Co., Ltd. the total number of shares held by the company to 1 billion 442 million shares, accounting for 93.22% of the total number of shares held by the company.

Trade and industry data show that the registered capital of Hong Mei Industrial 100 million yuan, a total of 3 shareholders, Ma Xingtian and his wife Xu Dongjin together hold 98.50% of the equity, the son Ma Wentian holds 1.50% of the equity. 3

(original title: Ma Xingtian business of the Kang Meihao gambling smart pharmacy)

Editor: Xiao Shen